| Jaime Cleary, CCC-SLP | |
|
75 Abington St, Hingham, MA 02043-4314 | |
| (339) 201-4572 | |
| Not Available |
| Full Name | Jaime Cleary |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 75 Abington St, Hingham, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386030435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 6406 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jaime Cleary, CCC-SLP 5 Queen Anne Ln, Hingham, MA 02043-3904 Ph: () - | Jaime Cleary, CCC-SLP 75 Abington St, Hingham, MA 02043-4314 Ph: (339) 201-4572 |
News Archive
Ortho Clinical Diagnostics today announced ORTHO VISION™ Max, a fully automated blood analyser for high-volume transfusion medicine laboratories, received CE Mark clearance, signifying its conformity with all EU regulation. It will be available for purchase in Europe and Japan in October.
A large analysis of more than 100 studies from around the world shows that exposure to pesticides, or bug and weed killers, and solvents is likely associated with a higher risk of developing Parkinson's disease. The research appears in the May 28, 2013, print issue of Neurology-, the medical journal of the American Academy of Neurology.
A recent survey of men and women in specific territories of Eastern Democratic Republic of the Congo found sexual violence and human rights violations were prevalent and were associated with physical and mental health outcomes, according to an article in the August 4 issue of JAMA, a theme issue on violence and human rights.
Cara Therapeutics, Inc. announced today that it had closed on a Series D financing of $15 million. The round was led by new investor, Rho Ventures, with participation from previous investors Alta Biopharma, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Healthcare Private Equity, Mitsubishi International Corporation and MVM Life Science Partners.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically significant safety concerns noted. Preliminary results demonstrated clinically significant improvements in percent change in forced expiratory volume in one second (FEV(1)).
› Verified 6 days ago
Cleary Speech & Language Services, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5 Queen Anne Ln, Hingham, MA 02043 Phone: 781-223-5596 | |
Jane H Sword, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Abington St, Hingham, MA 02043 Phone: 781-252-9696 | |
Caitlin Shea, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 196 Chief Justice Cushing Hwy, Hingham, MA 02043 Phone: 603-491-5342 | |
Ms. Elizabeth Jane Pedersen, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Winthrop Rd, Hingham, MA 02043 Phone: 781-749-7966 | |
Paige Gerenz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Sharp St, Hingham, MA 02043 Phone: 781-335-6663 | |
Wendy Gillen, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Lincoln St, Suite 202, Hingham, MA 02043 Phone: 617-840-5445 | |
Rachel Dimberio, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Sharp St, Hingham, MA 02043 Phone: 781-335-6663 |